$60.00 – $360.00Price range: $60.00 through $360.00
Tirzepatide peptide is a synthetic, research-grade peptide engineered as a dual agonist of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It is widely utilized in laboratory research to investigate metabolic regulation, insulin signaling, glucose homeostasis, and energy balance.
Its dual-receptor mechanism, combined with high stability and reproducibility, makes Tirzepatide a valuable tool for studying complex endocrine and metabolic pathways in controlled research environments.
Tirzepatide is a 39–amino acid synthetic incretin peptide designed to mimic the biological activity of both GIP and GLP-1 hormones. In experimental models, it binds to GIP and GLP-1 receptors, activating signaling pathways involved in insulin secretion, glucose metabolism, and appetite regulation.
In research settings, Tirzepatide peptide is commonly used to study:
Its dual incretin activity makes Tirzepatide especially useful for advanced metabolic and endocrine research.
| Property | Description |
|---|---|
| Peptide Name | Tirzepatide (Dual GIP/GLP-1 analogue) |
| Amino Acid Length | 39 |
| Purity | ≥98% (HPLC verified) |
| Form | Lyophilized powder |
| Molecular Weight | 4787.6 g/mol |
| Storage Temperature | –20°C (long-term storage) |
High-purity Tirzepatide peptide supports reliable, reproducible results in metabolic, endocrine, and cellular signaling research.
Tirzepatide peptide is intended exclusively for laboratory research. Common applications include:
Through controlled experimental use, Tirzepatide enables deeper insight into hormonal regulation, metabolic control, and receptor pharmacology.
To maintain peptide integrity and bioactivity:
Tirzepatide peptide is for laboratory research use only.
It is not approved for medical, veterinary, or human consumption.
Use is restricted to controlled laboratory environments by qualified professionals.
Q1: What makes Tirzepatide peptide unique in research?
Tirzepatide is a dual GIP/GLP-1 receptor analogue, allowing simultaneous activation of both incretin pathways—ideal for complex metabolic studies.
Q2: Is Tirzepatide approved for human use?
No. Research-grade Tirzepatide is not approved for human use and is intended only for experimental research.
Q3: What is the purity of Tirzepatide peptide?
High-quality Tirzepatide peptides are typically ≥98% pure, confirmed by HPLC testing.
Q4: How should Tirzepatide peptide be stored?
Store lyophilized at –20°C. After reconstitution, refrigerate at 2–8°C and avoid repeated freeze–thaw cycles.
Q5: What research fields commonly use Tirzepatide?
Tirzepatide is widely used in metabolic research, endocrinology, obesity studies, and molecular signaling investigations.
Tirzepatide peptide is a high-purity, research-grade dual GIP/GLP-1 receptor analogue designed for advanced studies in metabolic regulation, insulin signaling, glucose homeostasis, and energy balance.
Its dual-receptor activity, reproducibility, and structural stability make it an essential peptide for laboratories conducting endocrine, metabolic, and molecular biology research.

















